| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 123.65B | 121.24B | 108.54B | 104.78B | 91.86B | 82.67B |
| Gross Profit | 17.14B | 16.93B | 15.47B | 13.79B | 11.45B | 9.69B |
| EBITDA | 5.18B | 5.54B | 5.57B | 4.71B | 3.95B | 2.59B |
| Net Income | 2.63B | 2.97B | 2.95B | 2.91B | 2.25B | 1.47B |
Balance Sheet | ||||||
| Total Assets | 63.51B | 74.16B | 66.06B | 64.11B | 56.64B | 50.96B |
| Cash, Cash Equivalents and Short-Term Investments | 6.61B | 10.26B | 7.90B | 8.43B | 8.17B | 7.28B |
| Total Debt | 16.52B | 15.22B | 12.51B | 14.63B | 11.95B | 9.43B |
| Total Liabilities | 33.85B | 43.46B | 37.86B | 38.11B | 32.85B | 29.31B |
| Stockholders Equity | 28.88B | 29.89B | 27.41B | 25.23B | 23.04B | 20.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -32.90M | 3.13B | -1.54B | -1.07B | 4.06B |
| Operating Cash Flow | 0.00 | 251.24M | 3.60B | -96.77M | -539.21M | 4.57B |
| Investing Cash Flow | 0.00 | 309.92M | -764.62M | -1.24B | -280.79M | -311.41M |
| Financing Cash Flow | 0.00 | 1.51B | -3.54B | 1.45B | 1.47B | -2.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥29.21B | 4.79 | ― | 3.96% | 13.63% | 17.47% | |
79 Outperform | ¥121.00B | 9.20 | ― | 2.85% | 8.02% | 4.39% | |
76 Outperform | ¥14.16B | 7.37 | ― | 3.03% | 5.72% | 60.38% | |
68 Neutral | ¥31.98B | 8.57 | ― | 4.66% | -13.01% | 9.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | ¥45.31B | 6.79 | ― | 3.90% | 0.17% | 58.30% |